Author

BeiJun Chen

Observed names: B Y Chen, Beijun Chen, Biyun Chen

Institutions: National University of Singapore, Duke-NUS Medical School

Observed institutions: Fujian Medical University, National University of Singapore, Duke-NUS Medical School, Fujian Provincial Hospital, Union Hospital

ORCID: 0000-0003-3777-7609

Observed ORCID: 0000-0003-3777-7609

OpenAlex ID: A5012727472

[CRISPR/Cas9-mediated microRNA-21 knockout increased imatinib sensitivity in chronic myeloid leukemia cells].

2021 · Y Zhang, L Y Wang, et al. · PubMed · 6

Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients

2025 · Nuobing Yang, Hui Wang, et al. · Microbiology Spectrum · 1

[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].

2022 · Z J Lin, J Zha, et al. · PubMed · 1

Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia

2026 · Ilaria S. Pagani, Vaidehi Krishnan, et al. · HemaSphere

Single-cell chromatin profiling reveals early epigenetic reprogramming, subtype-specific regulatory networks, and JAK/STAT–IRF vulnerabilities in high-risk chronic myeloid leukemia

2025 · Sin Tiong Ong, Pavithra Shyamsunder, et al. · Blood

Mitochondrial DNA Mutations Determine Favourable Molecular Responses to Targeted Kinase Inhibitor Therapy and Impair Oxidative Phosphorylation

2025 · Ilaria S Pagani, Vaidehi Krishnan, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Imatinib-Sensitive Chronic Myeloid Leukaemia Is Associated with mtDNA Mutations and Reduced Oxphos Capacity

2024 · Ilaria Stefania Pagani, Vaidehi Krishnan, et al. · Blood

Works count: 7

Citation count: 8

H-index: 1

I10-index: